2016

August 02, 2016
BTG announces successful CE Mark reclassification for DC Bead® to Class III based on its ability to administer medicines

London, UK, 02 August 2016 BTG plc (LSE: BTG), a global specialist healthcare company, today announced that it has obtained European Conformity (CE) Mark from the Notified Body British Standards...

July 27 2016
BTG plc: Appointment of Non-executive Director

London, UK, 27 July 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces the appointment of Graham Hetherington as a non-executive director of the Board and Chair of the...

July 14, 2016
BTG plc: Annual General Meeting

London, UK, 14 July 2016 BTG plc (LSE: BTG), the specialist healthcare company provides the following business update ahead of its Annual General Meeting, which will be held today at 10.30 am at...

July 06 2016
Varithena® Earns FDA Approval for 30 Day Post-Activation Shelf Life

West Conshohocken, PA, US, 06 July 2016 BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation...

June 15, 2016
BTG completes the acquisition of Galil Medical

London, UK, 15 June 2016 BTG plc (LSE: BTG), the specialist healthcare company, is pleased to announce that it has completed the acquisition of Galil Medical, a leading provider of cryoablation...

Show 5102550100 per page
Top